Group 1: Cosmetics and Aesthetic Medicine Sector - The cosmetics retail sales growth in July and August 2025 was 4.5% and 5.1%, outperforming the overall retail market growth of 3.7% and 3.4%, indicating strong demand recovery [1][2] - The Q4 growth is expected to be boosted by the Double Eleven shopping festival and a relatively low base from the previous year, leading to further increases in cosmetics retail sales [1][2] - Domestic brands are leveraging online channels effectively, with notable performances from brands like Mao Geping and others on platforms like Taobao and Douyin [2] Group 2: Company Performance and Trends - Companies like Shuiyang and Beitaini are expected to turn profitable in Q3 2025, showing significant improvement compared to Q3 2024, which was affected by macroeconomic factors [3] - The performance of the aesthetic medicine sector is anticipated to be slightly weak due to macroeconomic influences, with both upstream and downstream segments facing challenges [4] - The mother and baby sector is gaining attention due to government subsidies, with companies like Kid King expected to see substantial profit growth [5] Group 3: Investment Recommendations - Recommended companies in the cosmetics sector include Mao Geping, Shangmei, and Shanghai Jahwa, which have strong growth in GMV [6] - Companies like Aimeike are highlighted for their strong profitability and product pipeline in the aesthetic medicine sector [6] - In the e-commerce and personal care brand space, companies like Ruoyuchen and Shuiyang are suggested for attention [7]
申万宏源:预计25Q3化妆医美整体表现符合预期 Q4持续向上